GlassScriptPhysician profile
Mailinh Thi Vu
NPI 1750793717
$4,802.08
in general payments reported to CMS, 2019-2025
31 companies · $733 in 2025
The $733 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $512 · 2021: $641 · 2022: $514 · 2023: $679 · 2024: $1,433 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,356 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,356.42 |
| Travel and Lodging | $487.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $776.20 | 2019-2023 | Lo Loestrin Fe |
| Medical Device Business Services, INC. | $552.40 | 2024 | Harmonic |
| Mayne Pharma Commercial LLC | $422.13 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $354.64 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $336.73 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $285.64 | 2021-2022 | |
| Ethicon US, LLC | $202.17 | 2020-2025 | Vistaseal, Ethicon, Stratafix |
| Therapeuticsmd, INC. | $189.53 | 2019-2021 | |
| Pfizer INC. | $164.65 | 2022-2024 | |
| Aspira Women'S Health INC | $161.06 | 2021-2024 | Ova1 |
| Organon LLC | $153.33 | 2023-2024 | Nexplanon |
| Davol INC. | $145.38 | 2020 | |
| Hologic Sales and Service, LLC | $140.86 | 2023-2025 | Aptima, Fluent Fluid Management System, Thinprep 2000 Processor |
| Intuitive Surgical, INC. | $140.30 | 2024 | |
| Medtronic, INC. | $102.86 | 2022-2025 | Ligasure |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $100.48 | 2021-2023 | |
| Coopersurgical, INC. | $77.76 | 2021-2025 | Ally II Ups |
| Shield Therapeutics INC | $76.52 | 2023-2024 | Accrufer |
| Sage Therapeutics, LLC | $73.52 | 2024-2025 | Zurzuvae |
| Meditrina | $53.48 | 2024-2025 | |
| Millicent US INC | $45.62 | 2025 | Femlyv |
| Allergan, INC. | $35.30 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $34.49 | 2020-2021 | |
| Lupin INC. | $29.81 | 2019 | |
| Astellas Pharma US INC | $29.18 | 2025 | Veozah |
| Dexcom, INC. | $28.74 | 2025 | Dexcom G6 Transmitter |
| Amag Pharmaceuticals, INC. | $23.11 | 2020 | |
| Mylan Pharmaceuticals INC. | $18.46 | 2020 | |
| Covidien LP | $16.42 | 2020 | |
| Avion Pharmaceuticals | $16.31 | 2023 | Balcoltra |
| Dysis Medical, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mailinh Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.